Aura Biosciences, Inc.
General ticker "AURA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $353.5M (TTM average)
Aura Biosciences, Inc. follows the US Stock Market performance with the rate: 10.7%.
Estimated limits based on current volatility of 3.8%: low 6.07$, high 6.54$
Factors to consider:
- Total employees count: 72 (+38.5%) as of 2022
- Top business risk factors: Operational and conduct risks, Labor/talent shortage/retention, Economic downturns and volatility, Regulatory and compliance, Geopolitical risks
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.63$, 12.94$]
- 2025-12-31 to 2026-12-31 estimated range: [4.53$, 10.77$]
Financial Metrics affecting the AURA estimates:
- Negative: with PPE of -4.7 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -19.51 <= 0.33
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 83.27 > 63.39
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 16.82 > -0.66
Short-term AURA quotes
Long-term AURA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $60.30MM | $84.99MM | $96.12MM |
| Operating Income | $-60.30MM | $-84.99MM | $-96.12MM |
| Non-Operating Income | $1.53MM | $8.72MM | $9.31MM |
| R&D Expense | $42.24MM | $63.94MM | $73.30MM |
| Income(Loss) | $-58.76MM | $-76.27MM | $-86.81MM |
| Taxes | $0.00MM | $0.14MM | $0.11MM |
| Profit(Loss)* | $-58.76MM | $-76.41MM | $-86.92MM |
| Stockholders Equity | $195.58MM | $225.85MM | $151.97MM |
| Assets | $223.94MM | $255.07MM | $182.50MM |
| Operating Cash Flow | $-54.60MM | $-63.85MM | $-79.81MM |
| Capital expenditure | $1.09MM | $0.71MM | $1.25MM |
| Investing Cash Flow | $-67.87MM | $-113.96MM | $68.82MM |
| Financing Cash Flow | $95.63MM | $97.29MM | $1.59MM |
| Earnings Per Share** | $-1.96 | $-1.93 | $-1.75 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.